W. R. Berkley Corporation Declares Special and Regular Quarterly Cash Dividends
W. R. Berkley Corporation Declares Special and Regular Quarterly Cash Dividends
W. R. Berkley Corporation (NYSE: WRB) announced today that its Board of Directors has declared a special cash dividend on its common stock of 25 cents per share to be paid on September 30,2024 to stockholders of record at the close of business on September 23, 2024.
In addition, the Board of Directors has declared a regular quarterly cash dividend on its common stock of 8 cents per share to be paid on September 30, 2024 to stockholders of record at the close of business on September 23, 2024. The per share dividend amount reflects the 3-for-2 common stock split effected on July 10, 2024.
Including today’s announced special and regular quarterly cash dividends and shares repurchased through June 30, 2024, total capital returned to shareholders during 2024 is approximately $535.3 million.
Founded in 1967, W. R. Berkley Corporation is an insurance holding company that is among the largest commercial lines writers in the United States and operates two segments of the property casualty insurance business: Insurance and Reinsurance & Monoline Excess. For further information about W. R. Berkley Corporation, please visit www.berkley.com.
Karen A. Horvath
Vice President – External
Financial Communications
203-629-3000
View source version on businesswire.com: https://www.businesswire.com/news/home/20240911178646/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks